Frost & Sullivan identifies 10 lucrative growth opportunities in Women’s Healthcare by 2030
Mita Srinivasan
10x Industry
Published:

Frost & Sullivan identifies 10 lucrative growth opportunities in Women’s Healthcare by 2030

With the requirement to deliver health equity for 4.3 billion women globally, the analysis highlights Women in Transition Symptoms Management & Holistic Care as an untapped high-growth potential market. The changing landscape of women's healthcare needs presents 10 lucrative growth opportunities by 2030.

Frost & Sullivan's recent analysis, Reimagining Women's Health, presented at Arab Health 2023, focused on the evolving healthcare issues of women and urges the healthcare industry to address them by developing holistic and personalized care delivery models. 

Frost & Sullivan identifies 10 lucrative growth opportunities in Women’s Healthcare by 2030
Supplied by Frost & Sullivan

With the requirement to deliver health equity for 4.3 billion women globally, the analysis highlights Women in Transition Symptoms Management & Holistic Care as an untapped high-growth  potential market. The changing landscape of women healthcare needs presents 10 lucrative growth opportunities by 2030 including:

  • A need for screening beyond breast cancer in emerging markets

  • Women-specific care for cardiac and diabetes

  • A need for affordable menstrual care solutions in emerging markets.

  • Advanced fertility solutions for developing markets

  • Increasing life expectancy and demand for longevity solutions presents opportunities for healthcare, wellness, cosmetics, aesthetics industries

  • Sexual health solutions will be required for menopausal women/cancer patients.

"To improve women's healthcare, we need the healthcare sectors to move beyond male mice  representation in pre-clinical trials and increase female representation from 20 percent to more," said Frost & Sullivan’s Healthcare and Life Sciences Partner and Senior Vice President, Reenita Das. "Additionally, despite the readiness of technology to deliver better healthcare for  women, the existing policy and reimbursement systems are refraining them from taking  advantage, so it is time for governments and concerned agencies to mull over such policies  and change them."

She added: "The step toward health equity begins with correcting language or terminology we  use. It is better to call 'women in transition' than menopause because it lasts for 20/30 years;  hence, it is not a 'pause'."

Reimagining Women's Health is the latest addition to Frost & Sullivan's Healthcare analysis  available through the Frost & Sullivan Leadership Council, which helps organizations identify a  continuous flow of growth opportunities to succeed in an unpredictable future.